Bone Marrow TransplantationBone MarrowBone Marrow CellsTransplantation, HomologousGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationAntineoplastic Combined Chemotherapy ProtocolsBone and BonesHematopoietic Stem Cell TransplantationAnemia, AplasticTransplantation ConditioningLeukemiaTransplantation ChimeraCyclophosphamideLiver TransplantationBone Marrow PurgingGraft SurvivalTissue DonorsBusulfanCombined Modality TherapyHematopoietic Stem CellsBone Marrow DiseasesHistocompatibility TestingTreatment OutcomeHistocompatibilityTransplantation, IsogeneicHematopoiesisRecurrenceBone Marrow ExaminationKidney TransplantationLeukemia, Myeloid, AcuteMice, Inbred C57BLRadiation ChimeraTime FactorsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaSurvival AnalysisHematologic NeoplasmsLymphoma, Non-HodgkinImmunosuppressive AgentsRemission InductionLeukemia, MyeloidGraft RejectionHepatic Veno-Occlusive DiseaseChemotherapy, AdjuvantBone RemodelingStem Cell TransplantationTransplantation ImmunologyGraft vs Host ReactionAcute DiseaseImmunosuppressionLymphocyte DepletionDisease-Free SurvivalColony-Forming Units AssaySurvival RateLeukocyte TransfusionEtoposideMyelodysplastic SyndromesHeart TransplantationT-LymphocytesSevere Combined ImmunodeficiencyActuarial AnalysisHematologic DiseasesChimeraCytarabineFollow-Up StudiesCarmustineHLA AntigensPrognosisRetrospective StudiesGranulocyte Colony-Stimulating FactorAntineoplastic AgentsLung TransplantationCyclosporineLymphocyte TransfusionBone DensityMelphalanCell DifferentiationPancytopeniaLeukocyte CountMethotrexateNuclear FamilyLymphomaHodgkin DiseaseMultiple MyelomaSpleenOrgan TransplantationGraft vs Tumor EffectFlow CytometryMice, Inbred BALB CGraft vs Leukemia EffectCytomegalovirus InfectionsDoxorubicinFatal OutcomeBone ResorptionCells, CulturedBone NeoplasmsAntigens, CD34